The impact of SMARCA4 loss in non-small cell lung cancer therapy
This case report explores the therapeutic impact of SMARCA4 loss in a 63-year-old female patient with a history of smoking, hypertension, hypercholesterolemia, and prior surgeries for breast and pancreatic carcinomas, who presented with a new pulmonary nodule. On February 23, 2024, a CT scan identif...
Saved in:
| Main Authors: | Mariano Lombardi, Marianna D'Ercole, Valeria Midolo De Luca, Matteo Chiari, Lorenzo Spaggiari, Luca Bertolaccini |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-01-01
|
| Series: | Heliyon |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844024171599 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Concurrent SMARCA4-deficient and poorly differentiated adenocarcinomas in separate lung lobes: a case report and literature review
by: Lu Wang, et al.
Published: (2025-05-01) -
SMARCA4-deficient NSCLC treated with first-line tislelizumab and fruquintinib achieved remarkable tumor regression: case report and literature review
by: Jie Dong, et al.
Published: (2025-04-01) -
Metastatic SMARCA4-deficient undifferentiated tumor in the small mesentery: case report
by: Shuai Luo, et al.
Published: (2024-12-01) -
Thoracic SMARCA4-deficient undifferentiated tumor
by: Yukina Izumi, et al.
Published: (2025-06-01) -
Case Report: FAP+ fibroblasts and SPP1+ macrophages in SMARCA2-deficient while SMARCA4-preserved poorly differentiated lung adenocarcinoma: two case reports and multi-omics analysis
by: Zhaoxuan Wang, et al.
Published: (2025-05-01)